Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma

Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma

Abstract Background Hodgkin’s lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with a life-time prevalence of cardiac disease exceeding 50%. In the late 1990s protocols were modified to reduce cancer therapy-related adverse...

Full description

Bibliographic Details
Main Authors: Anders W Bjerring, Knut HB Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Cardio-Oncology
Subjects:
Cancer survivorship
Hodgkin’s lymphoma
Echocardiography
Cardiotoxicity
Online Access:https://doi.org/10.1186/s40959-024-00222-4

Internet

https://doi.org/10.1186/s40959-024-00222-4

Similar Items